Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pooja, Kanani"'
Autor:
Sishir, Gang, Prakash, Khetan, Deepak, Varade, Venkata Ramakrishna, Chinta, Siddharth, Mavani, Umesh, Gupta, S Venkata Krishna, Reddy, Sunil, Rajanna, Tarun, Jeloka, Vivek, Ruhela, Kevinkumar, Kansagra, Pooja, Kanani, Jayesh, Bhatt, Kuldipsinh, Zala
Publikováno v:
American journal of nephrology. 53(5)
A phase 3 study to assess the efficacy and safety of the desidustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, against the epoetin alfa for the treatment of anemia in patients with chronic kidney disease (CKD) with dialysis depen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e39c252f1258d9396c5ad996ee3705ed
https://pubmed.ncbi.nlm.nih.gov/35462369
https://pubmed.ncbi.nlm.nih.gov/35462369
Autor:
Dhananjai, Agrawal, Deepak, Varade, Hardik, Shah, Alm, Nazar, Jayakumar, Krishnan, Vineet, Shukla, Chinta, Ramakrishna, Mahel Chinthana, Bandara Galahitiyawa, Sidhharth B, Mavani, Sunil, Rajanna, Petkar, Jikki, Shamila, De Silva, Vivek, Ruhela, Parshottam, Koradia, Kevinkumar, Kansagra, Pooja, Kanani, Nitin, Sharma, Kuldipsinh, Zala, Deven, Parmar
Publikováno v:
American journal of nephrology. 53(5)
Desidustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, is being developed to treat anemia in patients with chronic kidney disease (CKD) without dialysis dependency.In total, 588 patients with a clinical diagnosis of anemia due to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::918569e47f1760666da782b34c3873bf
https://pubmed.ncbi.nlm.nih.gov/35462372
https://pubmed.ncbi.nlm.nih.gov/35462372
Autor:
Jing Wu, Roberta Pugh, C. J. Peters, Richard Laughlin, John C. Morrill, Pooja Kanani, Nandadeva Lokugamage, Shinji Makino, L. Garry Adams
Publikováno v:
Vaccine. 31:4988-4994
The safety and immunogenicity of an authentic recombinant (ar) of the live, attenuated MP-12 Rift Valley fever (RVF) vaccine virus with a large deletion of the NSm gene in the pre-Gn region of the M RNA segment (arMP-12ΔNSm21/384) was tested in 4-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1509b9a12249f73a2aac7a1fdd1e41ee
https://doi.org/10.1016/j.vaccine.2013.08.003
https://doi.org/10.1016/j.vaccine.2013.08.003
Publikováno v:
Haemophilia. 18:e44-e45
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e79ba72d36541769cdc2ffb43a5bf97a
https://doi.org/10.1111/j.1365-2516.2011.02736.x
https://doi.org/10.1111/j.1365-2516.2011.02736.x